BioVeritas
Biotechnology ResearchTexas, United States51-200 Employees
BioVeritas is redefining the future of SAF by unlocking more feedstocks and using less energy to deliver superior carbon intensity.
Sustainable Innovation BioVeritas is actively advancing sustainable aviation fuel through proprietary processes that improve carbon intensity and expand feedstock options, highlighting opportunities for partnerships focused on eco-friendly fuel solutions.
Growing Production Capacity With recent facility expansions in Bryan, Texas and the launch of new SAF processes, BioVeritas is positioning itself for increased production scale, creating potential for supply chain collaborations and large-scale fuel procurement.
Leadership & Expertise The company’s strategic hires of senior leaders in business development and operations indicate a focus on commercial expansion and market penetration, presenting opportunities for sales teams to engage with key decision-makers.
Market Engagement BioVeritas’s participation in industry events like TopSoil Summit 2025 demonstrates active market engagement, providing channels for networking and forming strategic alliances in sustainable fuels and biochemicals markets.
Financial Stability With substantial funding and significant revenue, BioVeritas has a solid financial foundation, suggesting readiness to invest in new technologies and infrastructure, making it an attractive prospect for sales of innovative solutions and services.
BioVeritas uses 8 technology products and services including MySQL, Webpack, Sentry, and more. Explore BioVeritas's tech stack below.
| BioVeritas Email Formats | Percentage |
| FLast@bioveritas.com | 50% |
| FLast@bioveritas.com | 50% |
Biotechnology ResearchTexas, United States51-200 Employees
BioVeritas is redefining the future of SAF by unlocking more feedstocks and using less energy to deliver superior carbon intensity.
BioVeritas has raised a total of $65M of funding over 1 rounds. Their latest funding round was raised on Oct 26, 2022 in the amount of $65M.
BioVeritas's revenue is estimated to be in the range of $100M$250M
BioVeritas has raised a total of $65M of funding over 1 rounds. Their latest funding round was raised on Oct 26, 2022 in the amount of $65M.
BioVeritas's revenue is estimated to be in the range of $100M$250M